CoChat

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer

Open access
Keating, N. L., O'Malley, A. J., Freedland, S. J., Smith, M. R. · 2010 · JNCI Journal of the National Cancer Institute

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Previous studies indicate that androgen deprivation therapy for prostate cancer is associated with diabetes and cardiovascular disease among older men. We evaluated the relationship between androgen deprivation therapy and incident diabetes and cardiovascular disease in men of all ages with prostate cancer. METHODS: We conducted an observational study of 37,443 population-based men who were diagnosed with local or regional prostate cancer in the Veterans Healthcare Administration from January 1, 2001, through December 31, 2004, with follow-up through December 31, 2005. Cox proportional hazards models were used to assess whether androgen deprivation therapy with gonadotropin-releasing hormone (GnRH) agonists, oral antiandrogens, the combination of the two (ie, combined androgen blockade), or orchiectomy was associated with diabetes, coronary heart disease, myocardial infarction, sudden cardiac death, or stroke, after adjustment for patient and tumor characteristics. All statistical tests were two-sided. RESULTS: Overall, 14,597 (39%) of the 37,443 patients were treated with androgen deprivation therapy. Treatment with GnRH agonists was associated with statistically significantly increased risks of incident diabetes (for GnRH agonist therapy, 159.4 events per 1000 person-years vs 87.5 events for no androgen deprivation therapy, difference = 71.9, 95% confidence interval [CI] = 71.6 to 72.2; adjusted hazard ratio [aHR] = 1.28, 95% CI = 1.19 to 1.38), incident coronary heart disease (aHR = 1.19, 95% CI = 1.10 to 1.28), myocardial infarction (12.8 events per 1000 person-years for GnRH agonist therapy vs 7.3 for no androgen deprivation therapy, difference = 5.5, 95% CI = 5.4 to 5.6; aHR = 1.28, 95% CI = 1.08 to 1.52), sudden cardiac death (aHR = 1.35, 95% CI = 1.18 to 1.54), and stroke (aHR = 1.22, 95% CI = 1.10 to 1.36). Combined androgen blockade was statistically significantly associated with an increased risk of incident coronary heart disease (aHR = 1.27, 95% CI = 1.05 to 1.53), and orchiectomy was associated with coronary heart disease (aHR = 1.40, 95% CI = 1.04 to 1.87) and myocardial infarction (aHR = 2.11, 95% CI = 1.27 to 3.50). Oral antiandrogen monotherapy was not associated with any outcome studied. CONCLUSION: Androgen deprivation therapy with GnRH agonists was associated with an increased risk of diabetes and cardiovascular disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djp404

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 1

  1. National Committee for Quality Assurance. HEDIS 2004 Technical Specifications. Washington, DC: 2004. [Google Scholar]

Cited by

See all 643

Metadata

Authors
Keating, N. L., O'Malley, A. J., Freedland, S. J., & Smith, M. R.
Affiliations
Brigham and Women's Hospital (US)
Venue
JNCI Journal of the National Cancer Institute
Published
2009-12-07
Volume
102
Issue
1
Pages
39-46
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2140905531
Cited by
622
References
36
Citations by year
2026: 8 · 2025: 21 · 2024: 28 · 2023: 23 · 2022: 26 · 2021: 35 · 2020: 37 · 2019: 43 · 2018: 38 · 2017: 44 · 2016: 42 · 2015: 56 · 2014: 51 · 2013: 35 · 2012: 62
FWCI
32.19
Type
journal article
Language
en
Open access
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • National Institutes of Health (5k24ca121990-07)
  • National Cancer Institute (K24-CA121990)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Keywords
androgen deprivation therapy, prostate cancer, diabetes mellitus, cardiovascular disease, GnRH agonist, orchiectomy, androgen receptor antagonists, coronary artery disease, myocardial infarction, sudden cardiac death, stroke, veterans, cancer treatment side effects, older men, combined androgen blockade, adverse effects of hormone therapy, veterans' health care utilization, health care costs, health care utilization
MeSH terms
Administration, Oral, Aged, Androgen Antagonists, Cardiovascular Diseases, Coronary Artery Disease, Humans, Gonadotropin-Releasing Hormone, Male, Middle Aged, Myocardial Infarction, Orchiectomy, Prostatic Neoplasms, United States, Veterans, Confounding Factors, Epidemiologic, Proportional Hazards Models, Death, Sudden, Cardiac, Antineoplastic Agents, Hormonal, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer. https://app.cochat.ai/papers/10.1093/jnci/djp404
The paper
Keating, N. L., O'Malley, A. J., Freedland, S. J., & Smith, M. R. (2010). Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djp404

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.